Total investments received (USD): 6.03m
Round value (USD): 6.03m
Company: DeuterOncology
Industry:
Biotech
Health services

Netherlands
Austria
Germany
Switzerland
Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Sweden
France
Ireland
Italy
Portugal
Spain
United Kingdom